Profarm Seed India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -70.28%
- Profit Growth -274.41%
- Ebitda -250.32%
- Net Worth -11.24%
- Total Assets 10.40%
About Profarm Seed India
Profarm Seed India Private Limited (PSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 February 2007 and has a history of 17 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Proform Seed India Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ghulam Khan and Mary Magsaysay serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U01119TG2007PTC052976
-
Company No.
052976
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Feb 2007
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Profarm Seed India Private Limited offer?
Profarm Seed India Private Limited offers a wide range of products and services, including Food Grains, White Corn, Yellow Corn.
Who are the key members and board of directors at Profarm Seed India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghulam Khan
|
Director | 19-Jun-2018 | Current |
Mary Magsaysay
|
Director | 27-Feb-2007 | Current |
Financial Performance of Profarm Seed India.
Profarm Seed India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 70.28% decrease. The company also saw a substantial fall in profitability, with a 274.41% decrease in profit. The company's net worth observed a substantial decline by a decrease of 11.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Profarm Seed India?
In 2022, Profarm Seed India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Profarm Plantsciences Private LimitedGhulam Khan and Mary Magsaysay are mutual person
-
Victorymarvel Seeds India Private LimitedGhulam Khan and Mary Magsaysay are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Profarm Seed India?
Profarm Seed India has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Profarm Seed India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Profarm Seed India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
